Zions Bancorporation N.A. Purchases 2,816 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Zions Bancorporation N.A. grew its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 15.8% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 20,608 shares of the company’s stock after buying an additional 2,816 shares during the quarter. Zions Bancorporation N.A.’s holdings in HealthEquity were worth $1,687,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of HQY. Janney Montgomery Scott LLC raised its stake in HealthEquity by 27.4% in the first quarter. Janney Montgomery Scott LLC now owns 3,970 shares of the company’s stock worth $324,000 after buying an additional 855 shares in the last quarter. Swiss National Bank raised its stake in HealthEquity by 0.4% in the first quarter. Swiss National Bank now owns 169,300 shares of the company’s stock worth $13,820,000 after buying an additional 600 shares in the last quarter. US Bancorp DE raised its stake in HealthEquity by 4.8% in the first quarter. US Bancorp DE now owns 11,489 shares of the company’s stock worth $938,000 after buying an additional 521 shares in the last quarter. ProShare Advisors LLC raised its stake in HealthEquity by 5.7% in the first quarter. ProShare Advisors LLC now owns 19,477 shares of the company’s stock worth $1,590,000 after buying an additional 1,053 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System grew its holdings in HealthEquity by 11.1% in the first quarter. State Board of Administration of Florida Retirement System now owns 26,663 shares of the company’s stock worth $2,177,000 after purchasing an additional 2,660 shares during the period. 99.55% of the stock is owned by institutional investors.

HealthEquity Trading Up 0.9 %

Shares of HQY stock opened at $95.70 on Friday. HealthEquity, Inc. has a 12-month low of $62.10 and a 12-month high of $101.17. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The firm’s 50 day moving average is $84.56 and its 200 day moving average is $80.94. The stock has a market capitalization of $8.36 billion, a P/E ratio of 79.75, a P/E/G ratio of 1.48 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The company had revenue of $299.93 million for the quarter, compared to analysts’ expectations of $284.48 million. Research analysts expect that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

Insider Buying and Selling

In other HealthEquity news, Director Frank Corvino sold 1,247 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the transaction, the director now directly owns 4,823 shares in the company, valued at approximately $387,093.98. This trade represents a 20.54 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the transaction, the director now owns 54,719 shares in the company, valued at $4,540,582.62. The trade was a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 10,536 shares of company stock worth $884,517. 2.20% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HQY. Deutsche Bank Aktiengesellschaft upped their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. JMP Securities restated a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. Bank of America upped their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday. Royal Bank of Canada restated an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. Finally, BTIG Research upped their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $107.17.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.